TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
ICLR

ICON PLC

Healthcare · Diagnostics & Research

161.90$ -4.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

ICON PLC (ICLR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 8,251 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ICLR
Line item 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
42 56 81 116 157 226 226 297 346 456 631 865 888 900 946 1,115 1,336 1,503 1,575 1,666 1,758 2,596 2,806 2,797 5,481 7,741 8,120 8,282 8,251
– 29 42 64 83 122 122 163 220 256 354 489 508 541 612 718 845 903 909 961 1,031 1,826 1,974 1,989 3,973 5,527 5,720 5,845 6,076
42 27 39 52 73 103 103 134 126 199 276 376 380 359 334 397 491 600 666 705 727 769 832 808 1,508 2,214 2,400 2,436 2,176
– – 26 36 49 71 89 104 68 137 188 249 231 233 256 277 309 333 322 319 317 319 337 342 585 779 769 728 780
– 20 31 41 55 78 78 100 106 152 207 277 272 267 295 329 369 398 384 393 393 392 398 416 1,130 1,419 1,444 1,339 1,163
42 7.0 8.1 11 18 25 25 34 20 48 69 100 107 92 39 72 121 202 282 312 338 373 433 392 379 795 956 1,098 1,012
0.0 2.6 0.6 2.5 1.1 0.3 0.3 0.2 0.0 0.1 1.4 4.1 3.5 1.1 1.6 1.9 1.3 0.8 4.0 13 13 14 13 13 182 230 337 237 188
3.9 9.6 9.2 14 19 25 25 35 22 51 72 98 105 93 29 67 121 203 279 300 328 368 427 381 195 565 624 869 252
38 1.6 3.1 2.6 5.1 7.0 7.0 8.9 9.3 13 16 20 10 5.7 6.1 12 18 30 39 38 47 46 51 48 41 59 12 78 23
3.9 8.1 6.1 11 14 18 18 26 13 38 56 78 94 87 23 55 103 172 240 262 281 323 374 328 153 505 612 791 229
42 9.0 11 16 24 32 32 46 28 63 88 130 141 128 69 111 169 264 339 379 402 452 532 489 739 1,412 1,521 1,564 824

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?